These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 18447604

  • 1. Betahistine: what's new on the agenda?
    Barak N.
    Expert Opin Investig Drugs; 2008 May; 17(5):795-804. PubMed ID: 18447604
    [Abstract] [Full Text] [Related]

  • 2. Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results.
    Casani AP, Guidetti G, Schoenhuber R, Consensus Conference Group.
    Acta Otorhinolaryngol Ital; 2018 Oct; 38(5):460-467. PubMed ID: 30498275
    [Abstract] [Full Text] [Related]

  • 3. Betahistine or Cinnarizine for treatment of Meniere's disease.
    Djelilovic-Vranic J, Alajbegovic A, Tiric-Campara M, Volic A, Sarajlic Z, Osmanagic E, Todorovic L, Beslagic O.
    Med Arch; 2012 Oct; 66(6):396-8. PubMed ID: 23409520
    [Abstract] [Full Text] [Related]

  • 4. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
    Lian J, Huang XF, Pai N, Deng C.
    Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184
    [Abstract] [Full Text] [Related]

  • 5. Using betahistine in the treatment of patients with Menière's disease: a meta-analysis with the current randomized-controlled evidence.
    Devantier L, Hougaard D, Händel MN, Liviu-Adelin Guldfred F, Schmidt JH, Djurhuus B, Callesen HE.
    Acta Otolaryngol; 2020 Oct; 140(10):845-853. PubMed ID: 32580600
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hearing function after betahistine therapy in patients with Ménière's disease.
    Seyed Tootoonchi SJ, Ghiasi S, Shadara P, Samani SM, Fouladi DF.
    Braz J Otorhinolaryngol; 2016 Oct; 82(5):500-6. PubMed ID: 26810620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease.
    Liu JL, Liu JG, Chen XB, Liu YH.
    J Laryngol Otol; 2020 Dec; 134(12):1073-1076. PubMed ID: 33280619
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of Menière's disease with betahistine (author's transl)].
    Stupp H, Kahl S.
    HNO; 1976 Sep; 24(9):320-5. PubMed ID: 965272
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI, Poliakova TS, Vladimirova TN.
    Vestn Otorinolaringol; 1998 Sep; (5):49-50. PubMed ID: 9793432
    [Abstract] [Full Text] [Related]

  • 18. Betahistine decreases olanzapine-induced weight gain and somnolence in humans.
    Barak N, Beck Y, Albeck JH.
    J Psychopharmacol; 2016 Mar; 30(3):237-41. PubMed ID: 26839321
    [Abstract] [Full Text] [Related]

  • 19. Histaminergic H3-Heteroreceptors as a Potential Mediator of Betahistine-Induced Increase in Cochlear Blood Flow.
    Bertlich M, Ihler F, Freytag S, Weiss BG, Strupp M, Canis M.
    Audiol Neurootol; 2015 Mar; 20(5):283-93. PubMed ID: 26139562
    [Abstract] [Full Text] [Related]

  • 20. Effect of the H1-histamine receptor agonist betahistine on drinking and eating behavior in pygmy goats.
    Rossi R, Del Prete E, Scharrer E.
    Physiol Behav; 1999 May; 66(3):517-21. PubMed ID: 10357443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.